Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.745 USD | +12.98% | -9.10% | +6.39% |
Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
Apr. 18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
Evolution of the average Target Price on Ocular Therapeutix, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Ocular Therapeutix, Inc.
HC Wainwright | |
TD Cowen | |
JMP Securities | |
Piper Sandler | |
Baird | |
Raymond James | |
Berenberg Bank | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- OCUL Stock
- Consensus Ocular Therapeutix, Inc.